# The dual effects of anesthetics on glial cells: a review of neuroprotection and neurotoxicity

**Authors:** Xiaodong Wang, Minghe Zhao, Zhihui Liu

PMC · DOI: 10.3389/fphar.2026.1724695 · Frontiers in Pharmacology · 2026-01-26

## TL;DR

This paper reviews how anesthetics can both protect and harm glial cells in the brain, depending on the type and context of use.

## Contribution

The paper provides a comprehensive review of the dual effects of anesthetics on glial cells, highlighting their neuroprotective and neurotoxic potential.

## Key findings

- Local anesthetics like lidocaine protect glial cells by inducing autophagy and reducing inflammation.
- General anesthetics like isoflurane can cause astrocytic cytotoxicity and disrupt myelination in developing oligodendrocytes.
- Anesthetic effects on glial cells depend on type, concentration, exposure duration, and pathological context.

## Abstract

Glial cells—comprising astrocytes, microglia, and oligodendrocytes—are fundamental to central nervous system (CNS) homeostasis, yet their interactions with anesthetics are not fully elucidated. This review narratively synthesizes current evidence on the differential effects of local and general anesthetics on these cells, revealing a complex duality of neuroprotective and neurotoxic outcomes. Local anesthetics such as lidocaine can confer protection by inducing astrocytic autophagy and suppressing microglial pro-inflammatory responses, whereas bupivacaine may impair astrocytic mitochondrial function and potentiate excitotoxicity. Conversely, general anesthetics exhibit divergent impacts: propofol demonstrates protective properties against oxidative stress and neuroinflammation, but isoflurane often induces astrocytic cytotoxicity, activates microglia via the NF-κB pathway, and triggers apoptosis in developing oligodendrocytes, thereby disrupting myelination. These effects are critically influenced by anesthetic type, concentration, exposure duration, and the pathological context. Our analysis underscores the necessity of understanding these glial-centric mechanisms to optimize anesthetic safety, particularly for vulnerable populations such as the young and the elderly. Ultimately, advancing the knowledge of how anesthetics modulate glial cell function is pivotal for developing personalized anesthesia strategies that minimize neurotoxicity and harness potential protective effects, thereby improving postoperative neurological outcomes and guiding future translational research.

## Linked entities

- **Proteins:** NFKB1 (nuclear factor kappa B subunit 1)
- **Chemicals:** lidocaine (PubChem CID 3676), bupivacaine (PubChem CID 2474), propofol (PubChem CID 4943), isoflurane (PubChem CID 3763)

## Full-text entities

- **Genes:** NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}
- **Diseases:** inflammatory (MESH:D007249), neuroinflammation (MESH:D000090862), cytotoxicity (MESH:D064420), neurotoxic (MESH:D020258)
- **Chemicals:** propofol (MESH:D015742), isoflurane (MESH:D007530), bupivacaine (MESH:D002045), lidocaine (MESH:D008012)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12883979/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12883979/full.md

## References

59 references — full list in the complete paper: https://tomesphere.com/paper/PMC12883979/full.md

---
Source: https://tomesphere.com/paper/PMC12883979